Your trusted source for investing success

Tag: inc

Deep-South has Closed a Second Tranche of a Private Placement

Deep-South has Closed a Second Tranche of a Private Placement

Deep-South Resources Inc. (“Deep-South” or “the Company”) (TSXV:DSM) announces that it has closed a second tranche of its non-brokered private placement for gross proceeds of up to $227,700 (“the Offering”).

The non-brokered private placement comprises 1,035,000 units (the “Units”) of Deep-South, at a subscription price of $0.22 per Unit. Each Unit

Isodiol International Inc. Executes Definitive Agreement to Acquire 100% of C3 Global Biosciences™

Isodiol International Inc. Executes Definitive Agreement to Acquire 100% of C3 Global Biosciences™

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has entered into a definitive agreement with C3 Global Biosciences™ (C3GBS), a cause-driven organization committed to developing sustainable health solutions through the

Puma Exploration Closes A First Tranche Of Private Placement For $500,000

Puma Exploration Closes A First Tranche Of Private Placement For $500,000

Puma Exploration Inc. (the “Company” or “Puma) (TSXV:PUM)(SSE:PUMA) is pleased to announce the closing of a non-brokered private placement financing of flow-through units with qualified investors, employees and consultants. The Company issued 5,000,000 units at an issue price of $0.10 per flow-through units for gross proceeds of $500,000. The flow-through

Isodiol International Inc. Signs Definitive Agreement to Acquire 100% of Be Trū Organics™

Isodiol International Inc. Signs Definitive Agreement to Acquire 100% of Be Trū Organics™

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that it has finalized the definitive agreement to acquire 100% of Be Trū Organics™, a cause driven organization specializing in holistic products

WeedMD Added to Benchmark Index for Medical Marijuana ETF

WeedMD Added to Benchmark Index for Medical Marijuana ETF

WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally-licensed producer and distributor of medical cannabis, announces its inclusion in the North American Marijuana Index, the benchmark for the Horizons Marijuana Life Sciences ETF (TSX:HMMJ) (“HMMJ ETF”), the first exchange-traded fund (ETF) in the world to offer direct exposure to

Spearmint Announces Private Placement To Further Multiple Projects

Spearmint Announces Private Placement To Further Multiple Projects

Spearmint Resources Inc. (TSXV:SRJ) (OTCBB: SPMTF) (FSE: A2AHL5) (“SRJ” or the “Company”) announces that it intends to complete a private placement of up to 3,846,154 flow-through units (the “FT Units”) at a price of $0.065 per FT Unit for total gross proceeds of up to $250,000 and a private placement

Pasinex Announces Option to Acquire 80% of the Gunman High Grade Zinc (Silver) Project in Nevada and Substantially  Increases the Surrounding Ground Holding

Pasinex Announces Option to Acquire 80% of the Gunman High Grade Zinc (Silver) Project in Nevada and Substantially Increases the Surrounding Ground Holding

Pasinex Resources Limited (CSE:PSE) (FSE:PNX) (The “Company” or “Pasinex”) is pleased to announce that, through its wholly-owned subsidiary Pasinex Resources Nevada Limited, it has entered into an option agreement with Cypress Development Corp (TSXV:CYP) (“Cypress”) and Silcom Systems Inc. (“Silcom”) to earn up to an 80% interest in the Gunman

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
5 Top NASDAQ Biotech Stocks: Viking Therapeutics Leads the Week

URL: https://investingnews.com/daily/life-science-investing/biotech-investing/weekly-top-nasdaq-biotech-stocks/